SANDOSTATIN LAR FOR INJECTION 20 mg Сингапур - английский - HSA (Health Sciences Authority)

sandostatin lar for injection 20 mg

novartis (singapore) pte ltd - octreotide acetate 22.4mg eqv octreotide - injection - 20 mg/vial - octreotide acetate 22.4mg eqv octreotide 20 mg/vial

SANDOSTATIN LAR FOR INJECTION 30 mg Сингапур - английский - HSA (Health Sciences Authority)

sandostatin lar for injection 30 mg

novartis (singapore) pte ltd - octreotide acetate 33.6mg eqv octreotide - injection - 30 mg/vial - octreotide acetate 33.6mg eqv octreotide 30 mg/vial

IIrrigation fluid, medical/surgical procedure Австралия - английский - Department of Health (Therapeutic Goods Administration)

iirrigation fluid, medical/surgical procedure

bausch & lomb australia pty ltd - 37207 - irrigation fluid, medical/surgical procedure - balanced saline solution is indicated for ocular irrigation during ophthalmic surgery procedures.

Galexiclav 500 mg/125 mg Film-Coated Tablet Филиппины - английский - FDA (Food And Drug Administration)

galexiclav 500 mg/125 mg film-coated tablet

gamot philippines, inc.; distributor: galenica pharmaceuticals - co-amoxiclav - film-coated tablet - 500 mg/125 mg

ASMAHIST 50 mg/1 mg PER 5 mL Syrup Филиппины - английский - FDA (Food And Drug Administration)

asmahist 50 mg/1 mg per 5 ml syrup

interhealthcare pharmaceuticals, inc.; distributor: galenica pharmaceuticals, inc. - guaifenesin , salbutamol (as sulfate) - syrup - 50 mg/1 mg per 5 ml

Synazepam 2mg/5ml 2 mg/ 5ml Solution ОАЭ - английский - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

synazepam 2mg/5ml 2 mg/ 5ml solution

unicare medical trading l.l.c greece - 150 ml glass bottle - solution - 2 mg/ 5ml - central nervous system-antiepileptics

Ameluz Европейский союз - английский - EMA (European Medicines Agency)

ameluz

biofrontera bioscience gmbh - 5-aminolevulinic acid hydrochloride - keratosis, actinic; carcinoma, basal cell - antineoplastic agents - treatment of actinic keratosis of mild to moderate severity on the face and scalp (olsen grade 1 to 2; see section 5.1) and of field cancerization in adults.treatment of superficial and/or nodular basal cell carcinoma unsuitable for surgical treatment due to possible treatment-related morbidity and/or poor cosmetic outcome in adults.